All Updates

All Updates

icon
Filter
Funding
Listing
Clearmind Medicine plans USD 7.5 million underwritten public offering; lists on Nasdaq Capital Market
Psychedelic Medicine
Nov 14, 2022
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Psychedelic Medicine

Psychedelic Medicine

Nov 14, 2022

Clearmind Medicine plans USD 7.5 million underwritten public offering; lists on Nasdaq Capital Market

Funding
Listing

  • Vancouver-based psychedelic drugs company Clearmind Medicine announced its plans to raise USD 7.5 million via an underwritten public offering consisting of 1.2 million common shares priced at USD 6.50 per share. The company has offered a 45-day option to purchase an additional 15% (173,077) of common shares to Aegis Capital Corp which is also acting as the sole book-running manager for the offering. 

  • Furthermore, the company will also offer Aegis up to 57,692 warrants, with each warrant equivalent to one common share upon payment of USD 8.125 per share. 

  • Clearmind, which was listed on the Canadian Securities, has now been uplisted to the Nasdaq Capital Market with effect November 15, 2022, under the symbol “CMND”. 

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.